Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pro-platelet basic protein pseudogene 2 (PPBPP2) is classified as a pseudogene, meaning it does not encode a functional protein product. While its sequence may resemble that of protein-coding genes such as pro-platelet basic protein (PPBP/CXCL7), there is no evidence that PPBPP2 is expressed or biologically active, nor is it implicated as a therapeutic target or as a functional regulator in any known disease or pathway[1]. Important clarification: - *PPBPP2 (Pro-platelet basic protein pseudogene 2) is distinct from the actual **pro-platelet basic protein (PPBP / CXCL7)**, which is a chemokine with well-characterized biological and medical relevance*. PPBP is a chemoattractant and immune modulator[3][4][6], but PPBPP2, as a pseudogene, does **not** share these properties and should not be confused with the functional protein. Summary: PPBPP2 is a pseudogene, not a protein, enzyme, receptor, or any class of therapeutic target; there is no evidence for direct biological activity, drug interaction, or disease association[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pro-platelet basic protein pseudogene 2 (PPBPP2).